Triggering receptor expressed on myeloid cells-2 (TREM2) is expressed on TAMs and promotes immunosuppressive microenvironment formation and tumorigenesis in lung cancer, highlighting its potential as an immunotherapy target [88]. The gene discussed is TREM2; the disease is lung carcinoma.